Guangdong HEC associate adjusts share pledges

Yichang HEC Pharmaceutical, an associate of Guangdong HEC Technology Holding's controlling shareholder, recently announced the partial release and re-pledge of 15,000,000 shares. Following these transactions, Yichang HEC Pharmaceutical now holds 545,023,350 shares, representing 18.11% of the company's total share capital. The cumulative number of pledged shares held by Yichang HEC Pharmaceutical stands at 489,650,000, equating to 89.84% of its total holdings and 16.27% of Guangdong HEC's total share capital.

Simultaneously, Shenzhen HEC Industrial Development, the controlling shareholder, has 541,527,254 shares pledged, making up 87.37% of its holdings. Together, the controlling shareholder and its associates have 1,212,267,797 shares pledged, representing 76.23% of their combined holdings. The newly pledged shares by Yichang HEC Pharmaceutical, totaling 7,000,000 shares, are designated for production and operations, with the pledge maturing on October 17, 2025.

Guangdong HEC Technology Holding emphasizes that these pledge adjustments will not affect the company's operational activities, financing, or corporate governance. The company also stated there is no immediate risk of forced liquidation of the pledged shares.